Opexa Thera (OPXA) Hires Jay Thompson to Further Develop Tovaxin; Dawn McGuire to Become Chief Medical Officer

December 2, 2009 8:56 AM EST Send to a Friend
Opexa Therapeutics, Inc. (NASDAQ: OPXA) today announced that Jaye Thompson, Ph.D. has been hired to lead the Company's efforts to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login